Zacks Investment Research on MSN
Earnings preview: Pfizer (PFE) Q4 earnings expected to decline
Wall Street expects a year-over-year decline in earnings on lower revenues when Pfizer (PFE) reports results for the quarter ...
A month has gone by since the last earnings report for Pfizer (PFE). Shares have added about 3.9% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to ...
Pfizer will release its fourth-quarter earnings next month, and analysts anticipate a low double-digit profit dip.
Pfizer Inc. (PFE) shares are trading higher on Tuesday, as the stock benefits from a price target increase at Cantor ...
In the latest close session, Pfizer (PFE) was up +1.63% at $25.56. This move outpaced the S&P 500's daily loss of 0.53%. On ...
Pfizer PFE-0.02%decrease; red down pointing triangle issued its 2026 guidance, expecting its adjusted earnings per share to come in below this year’s figures, and revised its 2025 revenue outlook. The ...
Zacks Investment Research on MSN
Pfizer (PFE) outperforms broader market: What you need to know
In the latest trading session, Pfizer (PFE) closed at $25.90, marking a +1.49% move from the previous day. The stock's change ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results